Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136734 · ClinicalTrials.gov registry record · Phase 1
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 124
- Enrollment target
NCT00136734 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 124 participants.
The verdict
NCT00136734, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 124 participants
- Enrollment target
Study Summary
Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of methylphenidate in treating ADHD symptoms in cocaine dependent individuals.
Interventions
- OTHER placebo
- DRUG Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 1998-04 |
| Est. Completion | 2004-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136734
The ClinicalTrials.gov registry entry for NCT00136734 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00136734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136734 about?
NCT00136734 is a clinical study titled "Methylphenidate Treatment for Cocaine Abuse and ADHD - 1". Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of methylphenidate in treating ADHD sympto...
What is the current status of trial NCT00136734?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 124 participants. The study started on 1998-04. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00136734?
The interventions under investigation include: placebo (OTHER), Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00136734?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.